Enfermedad pulmonar intersticial asociada a esclerosis sistémica (EPI-ES)

 

Evidence-based consensus statements for the identification and management of interstitial lung disease in systemic sclerosis

Hoffamnn-Vold AM et al.
 

Acceder

Effect of nintedanib on progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD): further analyses of the SENSCIS trial

Khanna D et al.
 

Acceder

Effects of nintedanib in patients with extensive and limited systemic sclerosis-associated ILD (SSc-ILD): further analyses of the SENSCIS trial

Denton CP et al.
 

Acceder

 

 

Does dose adjustment affect decline in forced vital capacity in patients treated with nintedanib? Data from the SENSCIS trial

Mayes MD et al.
 

Acceder

Effect of nintedanib on progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD) over 100 weeks: data from the SENSCIS trial

Assassi S et al.
 

Acceder

Prevalence and clinical presentation of SSc-associated ILD according to worldwide spatial repartition in the EUSTAR database

Lescoat A et al.

 

Acceder

 

 

Which treatment aspects matter to patients with systemic sclerosis associated interstitial lung disease? The development of a patient preference instrument

Saketkoo LA et al.
 

Acceder

Disease frequency and characteristics of patients diagnosed with systemic sclerosis and systemic sclerosis associated interstitial lung disease: a US cohort study

Li Q et al.
 

Acceder

Immunosuppressant treatments and clinical outcomes among patients with systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study

Li Q et al.
 

Acceder

 

 

Management and burden of disease of SSc-ILD in eight European countries: results of the BUILDUP project

Wuyts W et al.


 

Acceder

Systemic sclerosis (SSc) with interstitial lung disease (SSc-ILD) in Canada’s largest province: an estimate of the prevalence and survival of SSc and SSc-ILD in Ontario over 10 years

Pope JE et al.
 

Acceder

The patient journey of SSc-ILD in Europe: an integrated analysis of healthcare professional and patient perspectives

Hoffmann-Vold AM et al.
 

Acceder

¿Te ha resultado útil esta información?